Skip to main content

Articles

Recent Articles

Media Statement: Labcorp has performed more than 12 million molecular tests to date: Reduces results delivery time to 1-2 days on average from specimen pickup
Articles  —  26 August Aug 2020

Media Statement: Labcorp has performed more than 12 million molecular tests to date: Reduces results delivery time to 1-2 days on average from specimen pickup

Read More about Media Statement: Labcorp has performed more than 12 million molecular tests to date: Reduces results delivery time to 1-2 days on average from specimen pickup
Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism
Articles  —  1 July Jul 2024

Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism

Read More about Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism
Phase I cGMP Drug Manufacture at the CRU: 3 BIG Benefits
Articles  —  19 May May 2021

Phase I cGMP Drug Manufacture at the CRU: 3 BIG Benefits

Read More about Phase I cGMP Drug Manufacture at the CRU: 3 BIG Benefits
Use of Luminex® Technology to Quantify Biomarkers and Provide Agent Efficacy
Articles  —  19 May May 2021

Use of Luminex® Technology to Quantify Biomarkers and Provide Agent Efficacy

Read More about Use of Luminex® Technology to Quantify Biomarkers and Provide Agent Efficacy
Media Statement: Labcorp capacity reaches average current daily volume of tests received
Articles  —  5 April Apr 2020

Media Statement: Labcorp capacity reaches average current daily volume of tests received

Read More about Media Statement: Labcorp capacity reaches average current daily volume of tests received
Presage sets the stage for commercial expansion with $13M financing and new Phase 0 trial agreements with Merck and Maverick Therapeutics
Articles  —  2 March Mar 2021

Presage sets the stage for commercial expansion with $13M financing and new Phase 0 trial agreements with Merck and Maverick Therapeutics

Read More about Presage sets the stage for commercial expansion with $13M financing and new Phase 0 trial agreements with Merck and Maverick Therapeutics
LabcorpISO17025Certificate.pdf
Articles  —  14 June Jun 2024

LabcorpISO17025Certificate.pdf

Read More about LabcorpISO17025Certificate.pdf
Labcorp and Rush University System for Health enter into a partnership focused on laboratory, clinical trial and data service
Articles  —  18 December Dec 2020

Labcorp and Rush University System for Health enter into a partnership focused on laboratory, clinical trial and data service

Read More about Labcorp and Rush University System for Health enter into a partnership focused on laboratory, clinical trial and data service
IND-enabling Programs for Gene and Cell Therapies Webinar Questions
Articles  —  7 June Jun 2021

IND-enabling Programs for Gene and Cell Therapies Webinar Questions

Read More about IND-enabling Programs for Gene and Cell Therapies Webinar Questions
We’ve got preferences and so do you
Articles  —  7 June Jun 2021

We’ve got preferences and so do you

Read More about We’ve got preferences and so do you
Technologies, tools and processes to support patient-centric oncology trials
Articles  —  9 December Dec 2021

Technologies, tools and processes to support patient-centric oncology trials

Read More about Technologies, tools and processes to support patient-centric oncology trials
Addressing the challenges of data management for pharmaceutical and biotechnology companies: introducing Laboratory FSPx
Articles  —  7 June Jun 2021

Addressing the challenges of data management for pharmaceutical and biotechnology companies: introducing Laboratory FSPx

Read More about Addressing the challenges of data management for pharmaceutical and biotechnology companies: introducing Laboratory FSPx